HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bin Jiang Selected Research

Tragacanth (Gum Tragacanth)

12/2014An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice.
9/2012Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bin Jiang Research Topics

Disease

110Neoplasms (Cancer)
09/2022 - 02/2004
30Neoplasm Metastasis (Metastasis)
01/2022 - 05/2003
20BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2016 - 04/2003
19Infections
02/2022 - 11/2011
18Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2003
17Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 11/2010
16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2019 - 02/2005
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 05/2007
15Stroke (Strokes)
11/2021 - 04/2006
15Lung Neoplasms (Lung Cancer)
04/2021 - 02/2004
13Carcinogenesis
01/2022 - 08/2008
13Hypertension (High Blood Pressure)
10/2021 - 08/2002
11Leukemia
01/2022 - 06/2002
11Acute Promyelocytic Leukemia
03/2015 - 05/2002
10Heart Failure
01/2021 - 09/2006
10Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018 - 08/2005
8Hypoxia (Hypoxemia)
01/2020 - 04/2007
8Philadelphia Chromosome
01/2018 - 03/2004
8Multiple Myeloma
06/2017 - 08/2008
7Glioma (Gliomas)
09/2022 - 01/2017
7Colitis
01/2022 - 05/2012
7Inflammation (Inflammations)
01/2022 - 05/2012
7Pain (Aches)
12/2021 - 06/2004
7Ischemic Stroke
11/2021 - 10/2008
7Carcinoma (Carcinomatosis)
11/2020 - 12/2006
7Hemorrhage
08/2020 - 02/2007
6Wounds and Injuries (Trauma)
10/2022 - 03/2009
6Stomach Neoplasms (Stomach Cancer)
04/2022 - 01/2013
6Melanoma (Melanoma, Malignant)
01/2022 - 07/2008
6Breast Neoplasms (Breast Cancer)
01/2022 - 01/2018
6Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 08/2013
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 05/2016
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2022 - 01/2019
5Disease Progression
01/2022 - 08/2008
5Fibrosis (Cirrhosis)
01/2022 - 09/2004
5Liver Neoplasms (Liver Cancer)
10/2021 - 05/2006
5Circulating Neoplastic Cells
04/2021 - 01/2019
5Squamous Cell Carcinoma of Head and Neck
01/2021 - 07/2016
5Lymphatic Metastasis
01/2021 - 12/2012
5Adenocarcinoma
01/2018 - 05/2007
4Hepatitis E
10/2022 - 01/2020
4COVID-19
02/2022 - 01/2021
4Body Weight (Weight, Body)
01/2022 - 09/2006
4Cognitive Dysfunction
01/2021 - 05/2011
4Adenocarcinoma of Lung
01/2021 - 07/2018
4Brain Neoplasms (Brain Tumor)
01/2021 - 01/2017
4Myasthenia Gravis
10/2019 - 11/2011
4Pathologic Constriction (Stenosis)
08/2019 - 06/2013
4Colonic Neoplasms (Colon Cancer)
01/2017 - 04/2012
4Thrombocytopenia (Thrombopenia)
08/2015 - 04/2003

Drug/Important Bio-Agent (IBA)

43Proteins (Proteins, Gene)FDA Link
04/2022 - 05/2006
28Biomarkers (Surrogate Marker)IBA
10/2022 - 10/2011
21Imatinib Mesylate (Gleevec)FDA Link
01/2016 - 04/2003
20Messenger RNA (mRNA)IBA
01/2022 - 06/2003
14Pharmaceutical PreparationsIBA
04/2022 - 12/2011
12Long Noncoding RNAIBA
01/2022 - 01/2017
11MicroRNAs (MicroRNA)IBA
01/2022 - 12/2013
11Biological ProductsIBA
01/2021 - 08/2005
9LigandsIBA
01/2022 - 04/2015
8Capsules (Microcapsules)IBA
02/2022 - 01/2013
8Glucose (Dextrose)FDA LinkGeneric
01/2021 - 04/2011
7RNA (Ribonucleic Acid)IBA
01/2022 - 01/2019
7LipidsIBA
01/2022 - 12/2007
7salicylhydroxamic acid (SHAM)IBA
04/2020 - 09/2006
6Small Interfering RNA (siRNA)IBA
03/2022 - 02/2011
6Blood Glucose (Blood Sugar)IBA
01/2022 - 07/2012
6Indicators and Reagents (Reagents)IBA
01/2022 - 05/2006
6Therapeutic UsesIBA
01/2022 - 01/2005
6ORALIT (ORS)IBA
05/2017 - 10/2004
6ArsenicIBA
01/2014 - 05/2002
6Bortezomib (Velcade)FDA Link
01/2014 - 08/2008
6Hemoglobins (Hemoglobin)IBA
02/2013 - 04/2003
5AcidsIBA
09/2022 - 01/2017
5ErbB Receptors (EGF Receptor)IBA
04/2022 - 02/2007
5Dextran SulfateIBA
01/2022 - 05/2010
5Cytarabine (Cytosar-U)FDA LinkGeneric
03/2015 - 08/2005
4CalciumIBA
01/2022 - 09/2006
4Cisplatin (Platino)FDA LinkGeneric
02/2021 - 01/2012
4Phosphotransferases (Kinase)IBA
01/2021 - 01/2011
4Morphine (MS Contin)FDA LinkGeneric
01/2021 - 01/2016
4HydrogelsIBA
01/2021 - 04/2012
4CateninsIBA
11/2020 - 01/2017
4CholesterolIBA
02/2020 - 03/2010
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 02/2011
4Cadherins (E-Cadherin)IBA
10/2019 - 01/2017
4Tyrosine Kinase InhibitorsIBA
01/2018 - 02/2005
4Fluorescein (Funduscein)FDA LinkGeneric
01/2018 - 01/2017
4Tobacco Smoke Pollution (Passive Smoking)IBA
04/2017 - 12/2007
4DNA (Deoxyribonucleic Acid)IBA
01/2017 - 08/2005
4AntigensIBA
02/2014 - 07/2008

Therapy/Procedure

57Therapeutics
01/2022 - 08/2002
29Drug Therapy (Chemotherapy)
10/2021 - 01/2005
12Liver Transplantation
01/2021 - 05/2003
6Aftercare (After-Treatment)
12/2020 - 08/2007
5Immunotherapy
01/2022 - 02/2016
5Electroacupuncture
01/2021 - 06/2008
5Transplantation
01/2019 - 02/2013
5Induction Chemotherapy
05/2017 - 11/2013
4Length of Stay
07/2018 - 07/2012
4Hematopoietic Stem Cell Transplantation
01/2018 - 03/2011